
Inhalers, nasal sprays, nose filters and home allergy kits.
The allergy firm ALK earns millions of kroner selling consumer products to people with allergies, and within a few years, this business area might become just as big as, if not bigger than the company's core market, injection and tablet-based vaccines, says ALK CEO Carsten Hellmann.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app